Akums Drugs and Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Amount in (₹ in Millions)

Period Ended Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Reserve of Surplus 6,808.85 6,885.76 6,076.69
Total Assets 35,163.65 32,665.27 30,690.48
Total Borrowings 4,915.55 5,369.73 3,579.53
Fixed Assets 10,649.06 9,631.51 9,320.28
Cash 1,110.50 516.08 551.39
Net Borrowing 3,805.05 4,853.65 3.028.14
Revenue 42,122.07 37,009.25 36,945.23
EBITDA 1,570.10 3,840.55 -690.89
PAT -36.78 20.06 -0.88
EPS -0.28 6.63 -17.65

Note 1:- ROCE & ROE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Other Comprehensive Income, Net of Tax) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after completion of an Offer.

Services

FNO Stocks with CA Abhay

Stock Market Masterclass

Equity Trading with CA Abhay

Equity Investment with CA Abhay

Option Trading with CA Abhay

Services

Equity Investment with CA Abhay

Option Trading with CA Abhay

Equity Trading with CA Abhay

Stock Market Masterclass

FNO Stocks with CA Abhay

onlyfans leakedonlyfan leaksonlyfans leaked videos